Mounjaro
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Mounjaro in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Mounjaro.
26
Global Revenue Ranking
1
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Mounjaro
The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels
Approximately 38.4 million people in the US are affected by diabetes
Patients treated with Lilly’s drug achieved an average weight reduction of 20.2%
The investment will provide an additional 200 jobs and more than 5,000 construction jobs during development of the site
You know, what with it being the end of the year and all that
The drug has been authorised for use alongside a reduced-calorie diet and physical activity
Lilly is the only FDA-approved company to legally sell products containing tirzepatide
Around 180,000 patients with type 2 diabetes could benefit from the new treatment option
In December 2022 increased demand resulted in a short supply of two of its diabetes drugs
Lilly’s projection for revenue in the new year is set to be between $30.3bn and $30.8bn
The company plans to initiate a rolling submission of a new drug application for tirzepatide this year
The new sites will create around 500 jobs within the company
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology